A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
Schennach-Wolff
R
R
Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany. Rebecca.Schennach-Wolff@med.uni-muenchen.de
Möller
H-J
HJ
Jäger
M
M
Seemüller
F
F
Obermeier
M
M
Messer
T
T
Laux
G
G
Pfeiffer
H
H
Naber
D
D
Schmidt
L G
LG
Gaebel
W
W
Klosterkötter
J
J
Heuser
I
I
Maier
W
W
Lemke
M R
MR
Rüther
E
E
Klingberg
S
S
Gastpar
M
M
Riedel
M
M